The CEO of French consumer goods giant Danone on Wednesday downplayed the threat of obesity drugs on its food business. Antoine de Saint-Affrique told CNBC that surging demand for drugs like Wegovy ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Stymied in its takeover bid for Lifeway Foods, minority ...

Danone is preparing litigation against kefir maker – and takeover target – Lifeway Foods, alleging the business broke a shareholder agreement between the two companies. An investor in Lifeway since ...

Danone has signed an agreement to sell its Swedish probiotic fruit juices brand ProViva to fellow dairy peer Lactalis for an undisclosed sum. The deal, signed with ProViva’s minority owner, dairy ...

Danone plans to double down on health and nutrition in the coming years as food companies seek to tackle the effects of Ozempic and other blockbuster weight-loss drugs on eating habits. Two years into ...

As the early signs of GLP-1-driven disruption emerge in the food sector, more manufacturers are exploring weight management-friendly innovation. The shift isn’t seismic yet, but momentum is building.

Divestitures in Q1-2024 indicate that management continues to execute its “Renew Danone” plan, with a primary focus still on internal reorganization. Net income has been battered by extraordinary ...